Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome

We investigated the effects of gut microbiota and serum metabolite levels in patients with Budd-Chiari syndrome (B-CS) and their importance for guiding clinical management strategies. In total, 214 B-CS patients (93 untreated and 121 treated) and 41 healthy controls were enrolled. Gut microbiota and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qinwei, Xu, Hao, Zhou, Lin, Zhang, Ruifang, Li, Zhen, Xu, Peng, Bai, Tao, Wang, Zhiwei, Wu, Gang, Ren, Jianzhuang, Jiao, Dechao, Song, Yan, Zhu, Rongtao, Li, Jian, Wang, Weijie, Liang, Ruopeng, Li, Lin, Ma, Xiuxian, Zu, Maoheng, Sun, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567795/
https://www.ncbi.nlm.nih.gov/pubmed/34746022
http://dx.doi.org/10.3389/fcimb.2021.730091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567795/
https://www.ncbi.nlm.nih.gov/pubmed/34746022
http://dx.doi.org/10.3389/fcimb.2021.730091

Ejemplares similares